If you have just received your first prescription for Ozempic, Wegovy, Mounjaro, or Zepbound, you are probably asking the same question thousands of new patients ask every week: How do I actually do this? The clinical trials that proved these medications work gave participants detailed injection training. You deserve the same level of detail.
This guide covers the complete injection protocol — from hand washing to sharps disposal — plus site rotation schedules to prevent the tissue damage that makes medication less effective, storage rules that protect your medication from degradation, and a device-by-device comparison of every GLP-1 pen currently on the market.
This guide provides general educational information about injection technique. It does not replace the training, counseling, or instructions provided by your prescribing physician or pharmacist. Always follow the specific instructions that came with your medication.
Understanding the Subcutaneous Layer: Why Placement Matters
GLP-1 receptor agonists like semaglutide and tirzepatide are subcutaneous injections — meaning the medication must be delivered into the fatty tissue layer that sits between the skin and the muscle beneath it. This is not the same as an intramuscular injection (the kind given in a doctor's office for vaccines) and it is not a simple skin-surface injection.
The subcutaneous layer acts as a slow-release depot. When medication enters this fatty tissue, it is absorbed gradually into the bloodstream over hours. This slow absorption is partly responsible for the once-weekly dosing schedule — the medication diffuses steadily rather than spiking and dropping as it would with intravenous or intramuscular delivery.
If you inject too shallow (into the skin itself, not beneath it), the injection site may become red, irritated, and the medication will not absorb properly. If you inject too deep (into muscle), absorption accelerates — potentially causing more side effects — and the injection is considerably more painful because muscle is far more densely innervated than subcutaneous fat. The 4mm ultra-short needle used in modern GLP-1 pens is specifically engineered to hit the subcutaneous sweet spot at a 90-degree insertion angle in virtually all body types.
Why 90 Degrees, Not 45?
Older injection guidelines sometimes recommended 45-degree insertion, borrowed from insulin injection practice when needles were longer (8–12mm). With the 32-gauge, 4mm needles used in current GLP-1 devices, a 90-degree angle (straight in, perpendicular to the skin surface) is correct for nearly all patients. The short needle simply cannot reach muscle at this length, even in very lean individuals. You do not need to angle the needle.
GLP-1 Device Guide: Ozempic, Wegovy, Mounjaro & Zepbound Compared
The four major GLP-1 medications use three different device formats, each with different priming requirements, dose settings, and hold times. Understanding your specific device before your first injection prevents dosing errors.
| Feature | Ozempic | Wegovy | Mounjaro / Zepbound |
|---|---|---|---|
| Drug | Semaglutide | Semaglutide | Tirzepatide |
| Device type | Prefilled multi-dose pen 3mL cartridge · 4 doses |
Single-use autoinjector One pen = one dose |
Single-use autoinjector (KwikPen) One pen = one dose |
| Dose settings | 0.5mg · 1mg · 2mg Dial to select dose |
Dose-locked per pen (0.25 → 0.5 → 1.0 → 1.7 → 2.4mg) |
Color-coded by dose 2.5 / 5 / 7.5 / 10 / 12.5 / 15mg |
| Priming required | Yes — new pen only | No | No |
| Button hold time | 6 seconds after counter reaches 0 | Press until click, then hold 10 seconds | Press until click, then hold 10 seconds |
| Needle | NovoFine Plus 32G × 4mm (included) | Fixed autoinjector needle (hidden) | Fixed autoinjector needle (hidden) |
| Unopened storage | Refrigerate 36–46°F | Refrigerate 36–46°F | Refrigerate 36–46°F |
| In-use room temp limit | 56 days (up to 77°F) | 28 days (up to 77°F) | 21 days (up to 86°F) |
| Pen lifespan | 4 weekly doses per pen | Single dose — discard after use | Single dose — discard after use |
Freezing destroys semaglutide and tirzepatide. Both are protein-based molecules — ice crystal formation during freezing permanently denatures their structure. A frozen-and-thawed pen looks normal but delivers inactive medication. If your medication has been frozen (accidentally left in a car in winter, or packed against ice packs), discard it and contact your pharmacy.
Step-by-Step Injection Protocol: All 10 Steps
Follow these steps in order for every injection. For Ozempic specifically, step 5 (priming) applies only to new pens. For Wegovy and Zepbound autoinjectors, skip the priming step entirely.
-
1
Wash hands thoroughly
Scrub with soap and water for a full 20 seconds. Injection site contamination is a rare but preventable complication. Dry hands completely before handling the pen.
-
2
Remove pen from refrigerator 30 minutes before injecting
Cold medication stings significantly more than room-temperature medication. Allowing the pen to warm up is a meaningful comfort improvement. Do not use a heat source to warm it — natural air warming only.
-
3
Inspect the medication
Check expiration date. Examine the medication through the window: semaglutide (Ozempic/Wegovy) should be clear and colorless. Tirzepatide (Mounjaro/Zepbound) should be clear to pale yellow. Discard any pen with cloudy, discolored, or particulate-containing medication — do not inject it.
-
4
Dial your dose (Ozempic) or select the correct pen (Wegovy/Zepbound)
For Ozempic: turn the dose selector to your prescribed dose setting. The dose counter window will display your dose. For single-use autoinjectors: verify the pen label matches your prescribed dose — the color coding helps, but always read the label.
-
5
Prime the Ozempic pen (new pen only, skip for Wegovy/Zepbound)
Attach a new needle, turn the dose selector to the flow-check symbol (the 0.01mg position), hold the pen with the needle pointing up, and press the dose button until a small drop of liquid appears at the needle tip. This removes air bubbles and confirms the pen is functioning. The priming dose is discarded — this is normal and expected.
-
6
Select and prepare your injection site
Choose abdomen (at least 2 inches from the navel), outer thigh, or outer upper arm. Abdomen provides the most consistent absorption and is the recommended default site. Clean with an alcohol swab if desired and allow to dry completely before injecting.
-
7
Gently pinch the skin
Using your non-dominant hand, gently pinch a fold of skin between your thumb and forefinger. This lifts the subcutaneous tissue away from the muscle beneath. Do not pinch hard enough to whiten the skin.
-
8
Insert needle at 90 degrees
With a quick, confident motion, insert the needle straight in — perpendicular to the skin surface. Hesitant, slow insertions increase discomfort. The needle is extremely thin (32G) and very short (4mm) — most patients find this far less painful than expected.
-
9
Inject and hold the full time
Press the injection button fully. For Ozempic: hold for 6 seconds after the dose counter returns to zero. For Wegovy and Zepbound: press until you hear or feel a click, then continue holding for 10 seconds. Releasing too early allows medication to leak back out of the injection channel — this is the most common cause of underdosing.
-
10
Remove needle, release pinch, and dispose of needle safely
Withdraw the needle straight out without angling. Release the skin pinch. Apply gentle pressure if needed — do not rub the site. Immediately dispose of the used needle (or pen) in a FDA-approved sharps container. Never recap needles. Never place in household trash or recycling.
Puncture-resistant, leak-proof container for safe disposal of GLP-1 pen needles. Required for safe home use — never place needles in household trash. Mail-back programs are also available for full containers.
View on Amazon →Site Rotation: The System That Protects Your Results
Site rotation is not optional maintenance advice — it is clinically essential. Repeatedly injecting into the same location causes lipohypertrophy: a localized buildup of thickened, fibrous fatty tissue at the overused site. Lipohypertrophic tissue looks and feels different from normal fat — it is harder, lumpier, and often less sensitive to pain (which perversely makes patients prefer it, since injections hurt less there).
The clinical problem with lipohypertrophy is profound: medication injected into this scarred tissue is absorbed unpredictably. The fibrous structure disrupts the normal diffusion channels. Patients who develop significant lipohypertrophy — common in type 1 diabetics who have injected insulin for years without rotating — experience wide swings in medication effectiveness that can be mistaken for dose failures. The same principle applies to GLP-1 therapy: if your weight loss has plateaued or your medication seems inconsistent, lipohypertrophy at a favored injection site is worth investigating with your prescriber.
The Three Approved Sites and Their Characteristics
Abdomen: The preferred primary site for most patients. The large surface area allows extensive rotation, and absorption is reliably consistent. Avoid the 2-inch zone immediately surrounding the navel — the tissue there is thicker and more fibrous, and absorption is less predictable.
Outer thigh: The anterior-lateral (front-outer) thigh surface provides a practical alternative, especially for self-injection without assistance. Avoid the inner thigh and the area directly above the knee. Absorption from the thigh is slightly slower than abdomen on average.
Outer upper arm: This site is frequently used when a partner or caregiver assists with injection. Self-injection into the arm is possible but more challenging due to limited access and pinching difficulty. Do not inject into the inner arm or near the shoulder joint.
Rotation Rules
Within each region, move the injection point at least 1 inch (2.5 cm) from the previous injection. You can use a mental grid system — dividing the abdomen into zones and systematically moving through them. Between injection sessions (weekly for GLP-1 therapy), also cycle between regions so that each site has maximum recovery time.
- Remove pen from fridge 30 min before dose time
- Check pen expiration and medication clarity
- Confirm correct dose dialed / correct pen selected
- Wash hands 20 seconds, dry completely
- Note last injection location, select rotated site
- Inspect site for lumps (signs of lipohypertrophy)
- Clean site, allow alcohol to fully dry
- Hold button for full 6–10 seconds after injection
- Dispose of needle in sharps container immediately
- Log injection: date, site, dose
(new zone)
(new zone)
Move injection point ≥1 inch within region. Track your pattern in a notebook or notes app.
Storage, Travel & Missed Doses
Refrigerator Storage (Unopened Pens)
All unopened GLP-1 pens must be refrigerated between 36°F and 46°F (2–8°C). Store them in the main body of the refrigerator — not in the door, where temperatures fluctuate with opening and closing. Keep pens away from the cooling element at the back of refrigerator shelves to prevent accidental freezing. Original packaging protects against light exposure.
Room Temperature Storage (In-Use Pens)
Once a pen has been used or removed from refrigeration for travel, the in-use room temperature limits apply: Ozempic can remain at room temperature (up to 77°F / 25°C) for up to 56 days. Wegovy pens, being single-use, should be injected and discarded the same day. Mounjaro and Zepbound can be at room temperature for up to 21 days (up to 86°F / 30°C). After these windows, discard the pen regardless of how much medication remains.
Traveling with GLP-1 Medication
The extended room-temperature stability of these medications — particularly Ozempic's 56-day window — makes travel considerably simpler than many patients expect. For most domestic trips, the pen can simply travel at room temperature without special cooling. For longer trips or hot climates, an insulated medication travel case with a cooling element (not ice packs that could freeze the medication) maintains safe temperatures.
When flying, carry medication in your carry-on bag — never in checked luggage, which may be exposed to freezing temperatures in cargo holds. TSA permits medically necessary liquids, gels, and injectable medications in quantities exceeding the standard 3.4oz limit when properly declared. Carry your prescription documentation and, for international travel, a letter from your prescriber. Needles should be capped and in original packaging for airport security.
TSA-compliant insulated case with cooling element to keep pens within safe temperature range during travel. Fits Ozempic, Wegovy, Mounjaro, and Zepbound pens with room for supplies.
View on Amazon →Dose Escalation Schedules
GLP-1 medications are started at low doses and increased gradually to minimize gastrointestinal side effects. The standard escalation schedule for semaglutide (Wegovy): 0.25mg for weeks 1–4, 0.5mg for weeks 5–8, 1.0mg for weeks 9–12, 1.7mg for weeks 13–16, and 2.4mg from week 17 onward as the maintenance dose.
For tirzepatide (Zepbound): 2.5mg for weeks 1–4, 5.0mg for weeks 5–8, then increasing by 2.5mg increments every 4 weeks as tolerated, up to a maximum of 15mg per dose. Your prescriber will set the target dose and may slow the escalation schedule if side effects are significant.
What to Do If You Miss a Dose
If you miss your scheduled weekly injection: if fewer than 5 days have passed since your missed dose day, administer the dose as soon as you remember. If more than 5 days have elapsed, skip the missed dose entirely and resume on your next regularly scheduled injection day. Never take two doses in the same week to compensate. Resume your normal weekly schedule from the day you restarted.
Common Injection Errors and How to Fix Them
Most injection technique problems fall into one of a small number of categories. Understanding them prevents weeks of suboptimal therapy.
Releasing the button before the full 6–10 seconds causes medication to leak back through the needle channel. Result: you receive less than your full dose. Always count aloud if needed.
Lumpy areas at favorite injection sites absorb medication unpredictably. If you notice lumps, report to your prescriber and avoid those sites for 2–3 months minimum.
Injecting straight from the refrigerator causes more stinging and discomfort. Let the pen warm at room temperature for 30 minutes before every injection.
A new Ozempic pen without priming may deliver air bubbles with the first dose. Only affects the new pen's first use — prime once, then no priming on subsequent uses.
Angling the needle or applying excess pressure can push a 4mm needle into muscle if the patient is very lean. Use the pinch technique and insert at true 90 degrees.
Using the same spot weekly for months creates lipohypertrophy. This is gradual and painless — patients often don't notice until absorption becomes erratic. Rotation must be systematic.
Pain Reduction Strategies
Modern GLP-1 needles are among the thinnest in clinical use (32 gauge, 4mm), and most patients find injections far less painful than anticipated. If you experience more than minimal discomfort, these strategies help: let the medication reach room temperature (the single most effective comfort intervention), relax the injection site muscle completely, insert the needle quickly and confidently (slow insertion increases pain), and hold the injection site gently with one or two fingers for a few seconds after withdrawal. Briefly icing the site before injection can help patients with significant needle anxiety, though this is rarely necessary once patients become comfortable with the process.
Safe Needle Disposal: Your Legal and Safety Obligations
Used needles and auto-injector pens are regulated medical waste. Improper disposal — placing them in household trash, recycling bins, or flushing them — creates real injury risks for sanitation workers and others who handle waste, and may be illegal in your state or municipality.
FDA-approved sharps containers are the standard disposal solution. These puncture-resistant, leak-proof containers are available at pharmacies, big-box retailers, and online. When the container is approximately three-quarters full (not overfull, to prevent overflow when closing), seal it for disposal.
Disposal options for full sharps containers include: mail-back programs (container manufacturers often include prepaid mailers), community collection sites at participating pharmacies and hospitals, and household hazardous waste programs run by local municipalities. The FDA's Safe Sharps Disposal website (safeneedledisposal.org) provides a searchable database of local drop-off sites. Never recap used needles — recapping is a significant cause of accidental needle-stick injuries.
Contact your prescriber if you notice: signs of infection at an injection site (increasing redness, warmth, swelling, pus), persistent pain that doesn't resolve within a day of injection, lumps or hard spots at injection sites that do not resolve, medication that appears cloudy, discolored, or has visible particles, or consistent pain significantly more severe than you experienced at the start of therapy.